Manipulation of Stretch-Induced Atriopeptin Prohormone Release and Processing in the Perfused Rat Heart

Atriopeptin (AP) is stored as the prohormone AP-126 [atrial natriuretic factor-(1-126)] in atrial granules. Cultured atrial myocytes synthesize and release only prohormone into the medium. HPLC analysis of the coronary venous effluent of media from perfused rat hearts subjected to right atrial stret...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 85; no. 21; pp. 8365 - 8369
Main Authors Ito, Takayuki, Toki, Yukio, Siegel, Ned, Gierse, James K., Needleman, Philip
Format Journal Article
LanguageEnglish
Published Washington, DC National Academy of Sciences of the United States of America 01.11.1988
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Atriopeptin (AP) is stored as the prohormone AP-126 [atrial natriuretic factor-(1-126)] in atrial granules. Cultured atrial myocytes synthesize and release only prohormone into the medium. HPLC analysis of the coronary venous effluent of media from perfused rat hearts subjected to right atrial stretch indicated the presence of the C-terminal mature hormone AP-28 [atrial natriuretic factor-(99-126)] and little or no prohormone. Absence of calcium from the perfusion medium increased total AP release and surprisingly blocked the proteolytic cleavage of the prohormone. Similarly, addition of the proteolytic inhibitor aprotinin to the perfusion medium suppressed the processing of the endogenous AP-126 released by atrial stretch. Aprotinin would be restricted to the extra-cellular space, which is therefore implicated as the site of prohormone processing. This suggestion was validated by the demonstration that the perfused rat heart could readily cleave exogenous prohormone to mature hormone, a process blocked by aprotinin. Hypothetically, the stimulus-release-processing event initiated by atrial stretch may require the concerted action of the synthetic cell (i.e., atrial myocyte) and a processing cell or site (e.g., the adjacent atrial mesenchymal cell) for the production of the mature AP-28, which is the circulating molecular form of this endocrine system.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.85.21.8365